Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-15

Clinical Trial Update: Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Triamcinolone Acetonide with Laser or Bevacizumab with Laser versus Laser Alone for diffuse non-tractional diabetic macular edema; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab with Laser (Bevacizumab)
  • Triamcinolone Acetonide with Laser (Triamcinolone Acetonide)
  • laser

Snippet

Sponsor: Hospital Universitario de Canarias | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED